BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 15885117)

  • 1. Fatty acyl moieties: improving Pro-rich peptide uptake inside HeLa cells.
    Fernández-Carneado J; Kogan MJ; Van Mau N; Pujals S; López-Iglesias C; Heitz F; Giralt E
    J Pept Res; 2005 Jun; 65(6):580-90. PubMed ID: 15885117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Replacement of a proline with silaproline causes a 20-fold increase in the cellular uptake of a Pro-rich peptide.
    Pujals S; Fernandez-Carneado J; Kogan MJ; Martinez J; Cavelier F; Giralt E
    J Am Chem Soc; 2006 Jul; 128(26):8479-83. PubMed ID: 16802813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proline-rich, amphipathic cell-penetrating peptides.
    Pujals S; Giralt E
    Adv Drug Deliv Rev; 2008 Mar; 60(4-5):473-84. PubMed ID: 18187229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Creation of a novel cell penetrating peptide, using a random 18mer peptides library.
    Nomura T; Kawamura M; Shibata H; Abe Y; Ohkawa A; Mukai Y; Sugita T; Imai S; Nagano K; Okamoto T; Tsutsumi Y; Kamada H; Nakagawa S; Tsunoda S
    Pharmazie; 2007 Aug; 62(8):569-73. PubMed ID: 17867548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-penetrating proline-rich peptidomimetics.
    Farrera-Sinfreu J; Giralt E; Royo M; Albericio F
    Methods Mol Biol; 2007; 386():241-67. PubMed ID: 18604949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shuttling gold nanoparticles into tumoral cells with an amphipathic proline-rich peptide.
    Pujals S; Bastús NG; Pereiro E; López-Iglesias C; Puntes VF; Kogan MJ; Giralt E
    Chembiochem; 2009 Apr; 10(6):1025-31. PubMed ID: 19322842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Highly efficient, nonpeptidic oligoguanidinium vectors that selectively internalize into mitochondria.
    Fernández-Carneado J; Van Gool M; Martos V; Castel S; Prados P; de Mendoza J; Giralt E
    J Am Chem Soc; 2005 Jan; 127(3):869-74. PubMed ID: 15656624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-penetrating cis-gamma-amino-l-proline-derived peptides.
    Farrera-Sinfreu J; Giralt E; Castel S; Albericio F; Royo M
    J Am Chem Soc; 2005 Jul; 127(26):9459-68. PubMed ID: 15984873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential peptide carriers: amphipathic proline-rich peptides derived from the N-terminal domain of gamma-zein.
    Fernández-Carneado J; Kogan MJ; Castel S; Giralt E
    Angew Chem Int Ed Engl; 2004 Mar; 43(14):1811-4. PubMed ID: 15054781
    [No Abstract]   [Full Text] [Related]  

  • 10. S4(13)-PV cell-penetrating peptide forms nanoparticle-like structures to gain entry into cells.
    Padari K; Koppel K; Lorents A; Hällbrink M; Mano M; Pedroso de Lima MC; Pooga M
    Bioconjug Chem; 2010 Apr; 21(4):774-83. PubMed ID: 20205419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methodological and cellular aspects that govern the internalization mechanisms of arginine-rich cell-penetrating peptides.
    Nakase I; Takeuchi T; Tanaka G; Futaki S
    Adv Drug Deliv Rev; 2008 Mar; 60(4-5):598-607. PubMed ID: 18045727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. D-SAP: a new, noncytotoxic, and fully protease resistant cell-penetrating peptide.
    Pujals S; Fernández-Carneado J; Ludevid MD; Giralt E
    ChemMedChem; 2008 Feb; 3(2):296-301. PubMed ID: 18058782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flow cytometric screening of cell-penetrating peptides for their uptake into embryonic and adult stem cells.
    Manceur A; Wu A; Audet J
    Anal Biochem; 2007 May; 364(1):51-9. PubMed ID: 17379177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Pro --> peptoid residue substitution on cell selectivity and mechanism of antibacterial action of tritrpticin-amide antimicrobial peptide.
    Zhu WL; Lan H; Park Y; Yang ST; Kim JI; Park IS; You HJ; Lee JS; Park YS; Kim Y; Hahm KS; Shin SY
    Biochemistry; 2006 Oct; 45(43):13007-17. PubMed ID: 17059217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of cell penetrating peptides fused to elastin-like polypeptide for drug delivery.
    Massodi I; Bidwell GL; Raucher D
    J Control Release; 2005 Nov; 108(2-3):396-408. PubMed ID: 16157413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct uptake routes of cell-penetrating peptide conjugates.
    Lundin P; Johansson H; Guterstam P; Holm T; Hansen M; Langel U; EL Andaloussi S
    Bioconjug Chem; 2008 Dec; 19(12):2535-42. PubMed ID: 19012426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-penetrating peptides as delivery vehicles for biology and medicine.
    Stewart KM; Horton KL; Kelley SO
    Org Biomol Chem; 2008 Jul; 6(13):2242-55. PubMed ID: 18563254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stability of cell-penetrating peptide-morpholino oligomer conjugates in human serum and in cells.
    Youngblood DS; Hatlevig SA; Hassinger JN; Iversen PL; Moulton HM
    Bioconjug Chem; 2007; 18(1):50-60. PubMed ID: 17226957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced intracellular delivery using arginine-rich peptides by the addition of penetration accelerating sequences (Pas).
    Takayama K; Nakase I; Michiue H; Takeuchi T; Tomizawa K; Matsui H; Futaki S
    J Control Release; 2009 Sep; 138(2):128-33. PubMed ID: 19465072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arginine-rich peptides and their internalization mechanisms.
    Futaki S; Nakase I; Tadokoro A; Takeuchi T; Jones AT
    Biochem Soc Trans; 2007 Aug; 35(Pt 4):784-7. PubMed ID: 17635148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.